Evidence map›Paper›PMID 42101329›Full record

ArticlePhysiologia plantarum

Evaluation of Bna.SCT and Bna.REF1 as Target Genes to Reduce Sinapine in Rapeseed Using a Protoplast-Based CRISPR RNP Approach.

Oliver Moss, Xueyuan Li, Selvaraju Kanagarajan, Eu Sheng Wang, Emelie Ivarson, Li-Hua Zhu

Abstract read
In one paragraph

Article in Physiologia plantarum. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Oliver MossDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.
Xueyuan LiDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.
Selvaraju KanagarajanDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.
Eu Sheng WangDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.
Emelie IvarsonDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.
Li-Hua ZhuDepartment of Plant Breeding, Swedish University of Agricultural Sciences, Lomma, Sweden.ORCID https://orcid.org/0000-0002-9325-3845

Funding

SLU Grogrund- Centre for Breeding of Food CropsThe Royal Physiographic Society of LundTrees and Crops for the Future (TC4F)
6 · The paper itself

Abstract

Rapeseed is a major oil crop worldwide, producing both oil and a high amount of protein. However, the use of its seed meal as a protein source for animal feed is limited by antinutritional factors, such as sinapine, which reduces nutrient absorption and affects the palatability. Efforts to reduce sinapine levels through conventional breeding have had limited success. Given the challenges of a changing climate and a growing global population, maximising crop utility, particularly the value of seed meal as a byproduct, is increasingly important. Genetic modification has been successfully used to reduce sinapine in rapeseed, but regulatory restrictions limit its commercial adoption in some regions. CRISPR-Cas gene editing, which is gaining broader global acceptance, offers a promising alternative to directly produce transgene-free mutants. In this study, we build on our previous work by generating transgene-free rapeseed mutants using protoplast-based CRISPR RNP gene editing. We successfully targeted the Bna.SCT and Bna.REF1 genes with editing efficiencies of 22%-63%, frequently achieving mutations in all four alleles of the target genes in T

Indexed as

Brassica napusCholineGene EditingPlant ProteinsCRISPR-Cas SystemsMutationPlants, Genetically ModifiedProtoplastsSeedsCholinePlant Proteinssinapineantinutritional factorsCRISPR RNP genome editingDNA‐freePEG‐mediated protoplast transfectionrapeseed seedcakesinapinetransgene‐free mutants

Identifiers

PMID42101329
PMCPMC13155187

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.